29 research outputs found
Comparative analysis of homology models of the Ah receptor ligand binding domain: Verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that mediates the biological and toxic effects of a wide variety of structurally diverse chemicals, including the toxic environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). While significant interspecies differences in AHR ligand binding specificity, selectivity, and response have been observed, the structural determinants responsible for those differences have not been determined, and homology models of the AHR ligand-binding domain (LBD) are available for only a few species. Here we describe the development and comparative analysis of homology models of the LBD of 16 AHRs from 12 mammalian and nonmammalian species and identify the specific residues contained within their ligand binding cavities. The ligand-binding cavity of the fish AHR exhibits differences from those of mammalian and avian AHRs, suggesting a slightly different TCDD binding mode. Comparison of the internal cavity in the LBD model of zebrafish (zf) AHR2, which binds TCDD with high affinity, to that of zfAHR1a, which does not bind TCDD, revealed that the latter has a dramatically shortened binding cavity due to the side chains of three residues (Tyr296, Thr386, and His388) that reduce the amount of internal space available to TCDD. Mutagenesis of two of these residues in zfAHR1a to those present in zfAHR2 (Y296H and T386A) restored the ability of zfAHR1a to bind TCDD and to exhibit TCDD-dependent binding to DNA. These results demonstrate the importance of these two amino acids and highlight the predictive potential of comparative analysis of homology models from diverse species. The availability of these AHR LBD homology models will facilitate in-depth comparative studies of AHR ligand binding and ligand-dependent AHR activation and provide a novel avenue for examining species-specific differences in AHR responsiveness. Ā© 2013 American Chemical Society
Induction of expression of aryl hydrocarbon receptor-dependent genes in human HepaRG cell line modified by shRNA and treated with Ī²-naphthoflavone
Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology
Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling
Inflammatory signaling plays a key role in tumor progression, and the pleiotropic cytokine interleukin-6 (IL-6) is an important mediator of protumorigenic properties. Activation of the aryl hydrocarbon receptor (AHR) with exogenous ligands coupled with inflammatory signals can lead to synergistic induction of IL6 expression in tumor cells. Whether there are endogenous AHR ligands that can mediate IL6 production remains to be established. The indoleamine-2,3-dioxygenase pathway is a tryptophan oxidation pathway that is involved in controlling immune tolerance, which also aids in tumor escape. We screened the metabolites of this pathway for their ability to activate the AHR; results revealed that kynurenic acid (KA) is an efficient agonist for the human AHR. Structure-activity studies further indicate that the carboxylic acid group is required for significant agonist activity. KA is capable of inducing CYP1A1 messenger RNA levels in HepG2 cells and inducing CYP1A-mediated metabolism in primary human hepatocytes. In a human dioxin response elementādriven stable reporter cell line, the EC25 was observed to be 104nM, while in a mouse stable reporter cell line, the EC25 was 10Ī¼M. AHR ligand competition binding assays revealed that KA is a ligand for the AHR. Treatment of MCF-7 cells with interleukin-1Ī² and a physiologically relevant concentration of KA (e.g., 100nM) leads to induction of IL6 expression that is largely dependent on AHR expression. Our findings have established that KA is a potent AHR endogenous ligand that can induce IL6 production and xenobiotic metabolism in cells at physiologically relevant concentrations
Antagonism of Aryl Hydrocarbon Receptor Signaling by 6,2ā²,4ā²-TrimethoxyflavoneSā
The aryl hydrocarbon receptor (AHR) is regarded as an important homeostatic
transcriptional regulator within physiological and pathophysiological processes,
including xenobiotic metabolism, endocrine function, immunity, and cancer. Agonist
activation of the AHR is considered deleterious based on toxicological evidence
obtained with environmental pollutants, which mediate toxic effects through AHR.
However, a multitude of plant-derived constituents, e.g., polyphenols that exhibit
beneficial properties, have also been described as ligands for the AHR. It is
conceivable that some of the positive aspects of such compounds can be attributed to
suppression of AHR activity through antagonism. Therefore, we conducted a dioxin
response element reporter-based screen to assess the AHR activity associated with a
range of flavonoid compounds. Our screen identified two flavonoids (5-methoxyflavone
and 7,4ā²-dimethoxyisoflavone) with previously unidentified AHR agonist
potential. In addition, we have identified and characterized
6,2ā²,4ā²-trimethoxyflavone (TMF) as an AHR ligand that
possesses the characteristics of an antagonist having the capacity to compete with
agonists, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and
benzo[a]pyrene, thus effectively inhibiting AHR-mediated
transactivation of a heterologous reporter and endogenous targets, e.g., CYP1A1,
independent of cell lineage or species. Furthermore, TMF displays superior action by
virtue of having no partial agonist activity, in contrast to other documented
antagonists, e.g., Ī±-napthoflavone, which are partial weak agonists. TMF
also exhibits no species or promoter dependence with regard to AHR antagonism. TMF
therefore represents an improved tool allowing for more precise dissection of AHR
function in the absence of any conflicting agonist activity